Human metapneumovirus in adults

Lenneke E M Haas, Steven F T Thijsen, Leontine van Elden, Karen A Heemstra, Lenneke E M Haas, Steven F T Thijsen, Leontine van Elden, Karen A Heemstra

Abstract

Human metapneumovirus (HMPV) is a relative newly described virus. It was first isolated in 2001 and currently appears to be one of the most significant and common human viral infections. Retrospective serologic studies demonstrated the presence of HMPV antibodies in humans more than 50 years earlier. Although the virus was primarily known as causative agent of respiratory tract infections in children, HMPV is an important cause of respiratory infections in adults as well. Almost all children are infected by HMPV below the age of five; the repeated infections throughout life indicate transient immunity. HMPV infections usually are mild and self-limiting, but in the frail elderly and the immunocompromised patients, the clinical course can be complicated. Since culturing the virus is relatively difficult, diagnosis is mostly based on a nucleic acid amplification test, such as reverse transcriptase polymerase chain reaction. To date, no vaccine is available and treatment is supportive. However, ongoing research shows encouraging results. The aim of this paper is to review the current literature concerning HMPV infections in adults, and discuss recent development in treatment and vaccination.

References

    1. Freymuth F., Vabret A., Gouarin S., Petitjean J., Charbonneau P., Lehoux P., Galateau-Salle F., Tremolieres F., Carette M.F., Mayaud C., et al. Epidemiology and diagnosis of respiratory syncitial virus in adults. Rev. Mal. Respir. 2004;21:35–42.
    1. Osterhaus A., Fouchier R. Human metapneumovirus in the community. Lancet. 2003;361:890–891. doi: 10.1016/S0140-6736(03)12785-7.
    1. Falsey A.R., Erdman D., Anderson L.J., Walsh E.E. Human metapneumovirus infections in young and elderly adults. J. Infect. Dis. 2003;187:785–790. doi: 10.1086/367901.
    1. van den Hoogen B.G., de Jong J.C., Groen J., Kuiken T., de Groot R., Fouchier R.A., Osterhaus A.D. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 2001;7:719–724. doi: 10.1038/89098.
    1. Stockton J., Stephenson I., Fleming D., Zambon M. Human metapneumovirus as a cause of community-acquired respiratory illness. Emerg. Infect. Dis. 2002;8:897–901. doi: 10.3201/eid0809.020084.
    1. Boivin G., Abed Y., Pelletier G., Ruel L., Moisan D., Cote S., Peret T.C., Erdman D.D., Anderson L.J. Virological features and clinical manifestations associated with human metapneumovirus: A new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J. Infect. Dis. 2002;186:1330–1334. doi: 10.1086/344319.
    1. Peret T.C., Boivin G., Li Y., Couillard M., Humphrey C., Osterhaus A.D., Erdman D.D., Anderson L.J. Characterization of human metapneumoviruses isolated from patients in North America. J. Infect. Dis. 2002;185:1660–1663. doi: 10.1086/340518.
    1. Widmer K., Zhu Y., Williams J.V., Griffin M.R., Edwards K.M., Talbot H.K. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J. Infect. Dis. 2012;206:56–62. doi: 10.1093/infdis/jis309.
    1. Walsh E.E., Peterson D.R., Falsey A.R. Human metapneumovirus infections in adults: Another piece of the puzzle. Ann. Intern. Med. 2008;168:2489–2496. doi: 10.1001/archinte.168.22.2489.
    1. Biacchesi S., Skiadopoulos M.H., Boivin G., Hanson C.T., Murphy B.R., Collins P.L., Buchholz U.J. Genetic diversity between human metapneumovirus subgroups. Virology. 2003;315:1–9. doi: 10.1016/S0042-6822(03)00528-2.
    1. Agapov E., Sumino K.C., Gaudreault-Keener M., Storch G.A., Holtzman M.J. Genetic variability of human metapneumovirus infection: Evidence of a shift in viral genotype without a change in illness. J. Infect. Dis. 2006;193:396–403. doi: 10.1086/499310.
    1. van den Hoogen B.G., Herfst S., Sprong L., Cane P.A., Forleo-Neto E., de Swart R.L., Osterhaus A.D., Fouchier R.A. Antigenic and genetic variability of human metapneumoviruses. Emerg. Infect. Dis. 2004;10:658–666. doi: 10.3201/eid1004.030393.
    1. Mackay I.M., Bialasiewicz S., Jacob K.C., McQueen E., Arden K.E., Nissen M.D., Sloots T.P. Genetic diversity of human metapneumovirus over 4 consecutive years in Australia. J. Infect. Dis. 2006;193:1630–1633. doi: 10.1086/504260.
    1. Skiadopoulos M.H., Biacchesi S., Buchholz U.J., Riggs J.M., Surman S.R., Amaro-Carambot E., McAuliffe J.M., Elkins W.R., St Claire M., Collins P.L., et al. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness. J. Virol. 2004;78:6927–6937.
    1. Huck B., Scharf G., Neumann-Haefelin D., Puppe W., Weigl J., Falcone V. Novel human metapneumovirus sublineage. Emerg. Infect. Dis. 2006;12:147–150. doi: 10.3201/eid1201.050772.
    1. Schildgen V., van den Hoogen B., Fouchier R., Tripp R.A., Alvarez R., Manoha C., Williams J., Schildgen O. Human metapneumovirus: Lessons learned over the first decade. Clin. Microbiol. Rev. 2011;24:734–754. doi: 10.1128/CMR.00015-11.
    1. Hamelin M.E., Yim K., Kuhn K.H., Cragin R.P., Boukhvalova M., Blanco J.C., Prince G.A., Boivin G. Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats. J. Virol. 2005;79:8894–8903. doi: 10.1128/JVI.79.14.8894-8903.2005.
    1. Hamelin M.E., Prince G.A., Gomez A.M., Kinkead R., Boivin G. Human metapneumovirus infection induces long-term pulmonary inflammation associated with airway obstruction and hyperresponsiveness in mice. J. Infect. Dis. 2006;193:1634–1642. doi: 10.1086/504262.
    1. Darniot M., Pitoiset C., Petrella T., Aho S., Pothier P., Manoha C. Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c mice. J. Virol. 2009;83:3323–3332. doi: 10.1128/JVI.02198-08.
    1. Ditt V., Lusebrink J., Tillmann R.L., Schildgen V., Schildgen O. Respiratory infections by HMPV and RSV are clinically indistinguishable but induce different host response in aged individuals. PLoS One. 2011;6:e16314.
    1. Lusebrink J., Wiese C., Thiel A., Tillmann R.L., Ditt V., Muller A., Schildgen O., Schildgen V. High seroprevalence of neutralizing capacity against human metapneumovirus in all age groups studied in Bonn, Germany. Clin. Vaccine Immunol. 2010;17:481–484. doi: 10.1128/CVI.00398-09.
    1. Sastre P., Ruiz T., Schildgen O., Schildgen V., Vela C., Rueda P. Seroprevalence of human respiratory syncytial virus and human metapneumovirus in healthy population analyzed by recombinant fusion protein-based enzyme linked immunosorbent assay. Virol. J. 2012;9:130-422X-9-130. doi: 10.1186/1743-422X-9-130.
    1. Falsey A.R., Hennessey P.A., Formica M.A., Criddle M.M., Biear J.M., Walsh E.E. Humoral immunity to human metapneumovirus infection in adults. Vaccine. 2010;28:1477–1480.
    1. van den Hoogen B.G., van Doornum G.J., Fockens J.C., Cornelissen J.J., Beyer W.E., de Groot R., Osterhaus A.D., Fouchier R.A. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J. Infect. Dis. 2003;188:1571–1577. doi: 10.1086/379200.
    1. Williams J.V., Wang C.K., Yang C.F., Tollefson S.J., House F.S., Heck J.M., Chu M., Brown J.B., Lintao L.D., Quinto J.D., et al. The role of human metapneumovirus in upper respiratory tract infections in children: A 20-year experience. J. Infect. Dis. 2006;193:387–395. doi: 10.1086/499274.
    1. Esper F., Martinello R.A., Boucher D., Weibel C., Ferguson D., Landry M.L., Kahn J.S. A 1-year experience with human metapneumovirus in children aged <5 years. J. Infect. Dis. 2004;189:1388–1396. doi: 10.1086/382482.
    1. Williams J.V., Harris P.A., Tollefson S.J., Halburnt-Rush L.L., Pingsterhaus J.M., Edwards K.M., Wright P.F., Crowe J.E., Jr. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. New Engl. J. Med. 2004;350:443–450. doi: 10.1056/NEJMoa025472.
    1. Williams J.V., Edwards K.M., Weinberg G.A., Griffin M.R., Hall C.B., Zhu Y., Szilagyi P.G., Wang C.K., Yang C.F., Silva D., et al. Population-based incidence of human metapneumovirus infection among hospitalized children. J. Infect. Dis. 2010;201:1890–1898. doi: 10.1086/652782.
    1. Boivin G., De Serres G., Cote S., Gilca R., Abed Y., Rochette L., Bergeron M.G., Dery P. Human metapneumovirus infections in hospitalized children. Emerg. Infect. Dis. 2003;9:634–640. doi: 10.3201/eid0906.030017.
    1. Mullins J.A., Erdman D.D., Weinberg G.A., Edwards K., Hall C.B., Walker F.J., Iwane M., Anderson L.J. Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg. Infect. Dis. 2004;10:700–705. doi: 10.3201/eid1004.030555.
    1. van den Hoogen B.G., Osterhaus D.M., Fouchier R.A. Clinical impact and diagnosis of human metapneumovirus infection. J. Pediatr. Infect. Dis. 2004;23:S25–S32. doi: 10.1097/01.inf.0000108190.09824.e8.
    1. Crowe J.E., Jr. Human metapneumovirus as a major cause of human respiratory tract disease. J. Pediatr. Infect. Dis. 2004;23:S215–21. doi: 10.1097/01.inf.0000144668.81573.6d.
    1. Debiaggi M., Canducci F., Ceresola E.R., Clementi M. The role of infections and coinfections with newly identified and emerging respiratory viruses in children. Virol. J. 2012;9:247. doi: 10.1186/1743-422X-9-247.
    1. Hustedt J.W., Vazquez M. The changing face of pediatric respiratory tract infections: how human metapneumovirus and human bocavirus fit into the overall etiology of respiratory tract infections in young children. Yale J. Biol. Med. 2010;83:193–200.
    1. Papenburg J., Boivin G. The distinguishing features of human metapneumovirus and respiratory syncytial virus. Rev. Med. Virol. 2010;20:245–260. doi: 10.1002/rmv.651.
    1. Papenburg J., Hamelin M.E., Ouhoummane N., Carbonneau J., Ouakki M., Raymond F., Robitaille L., Corbeil J., Caouette G., Frenette L., et al. Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children. J. Infect. Dis. 2012;206:178–189. doi: 10.1093/infdis/jis333.
    1. Pavlin J.A., Hickey A.C., Ulbrandt N., Chan Y.P., Endy T.P., Boukhvalova M.S., Chunsuttiwat S., Nisalak A., Libraty D.H., Green S., et al. Human metapneumovirus reinfection among children in thailand determined by elisa using purified soluble fusion protein. J. Infect. Dis. 2008;198:836–842. doi: 10.1086/591186.
    1. van den Hoogen B.G., Herfst S., de Graaf M., Sprong L., van Lavieren R., van Amerongen G., Yuksel S., Fouchier R.A., Osterhaus A.D., de Swart R.L. Experimental infection of macaques with human metapneumovirus induces transient protective immunity. J. Gen. Virol. 2007;88:1251–1259. doi: 10.1099/vir.0.82663-0.
    1. Falsey A.R. Respiratory syncytial virus infection in elderly and high-risk adults. Exp. Lung Res. 2005;31:77.
    1. Matsuzaki Y., Itagaki T., Ikeda T., Aoki Y., Abiko C., Mizuta K. Human metapneumovirus infection among family members. Epidemiol. Infect. 2012:1–6.
    1. Tu C.C., Chen L.K., Lee Y.S., Ko C.F., Chen C.M., Yang H.H., Lee J.J. An outbreak of human metapneumovirus infection in hospitalized psychiatric adult patients in Taiwan. Scand. J. Infect. Dis. 2009;41:363–367. doi: 10.1080/00365540902849375.
    1. Kim S., Sung H., Im H.J., Hong S.J., Kim M.N. Molecular epidemiological investigation of a nosocomial outbreak of human metapneumovirus infection in a pediatric hemato-oncology patient population. J. Clin. Microbiol. 2009;47:1221–1224. doi: 10.1128/JCM.01959-08.
    1. Te Wierik M.J., Nguyen D.T., Beersma M.F., Thijsen S.F., Heemstra K.A. An outbreak of severe respiratory tract infection caused by human metapneumovirus in a residential care facility for elderly in Utrecht, the Netherlands, January to March 2010. Euro. Surveill. 2012;17:20132.
    1. Peiris J.S., Tang W.H., Chan K.H., Khong P.L., Guan Y., Lau Y.L., Chiu S.S. Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerg. Infect. Dis. 2003;9:628–633. doi: 10.3201/eid0906.030009.
    1. Bruno R., Marsico S., Minini C., Apostoli P., Fiorentini S., Caruso A. Human metapneumovirus infection in a cohort of young asymptomatic subjects. New. Microbiol. 2009;32:297–301.
    1. Falsey A.R., Criddle M.C., Walsh E.E. Detection of respiratory syncytial virus and human metapneumovirus by reverse transcription polymerase chain reaction in adults with and without respiratory illness. J. Clin. Virol. 2006;35:46–50. doi: 10.1016/j.jcv.2005.04.004.
    1. Hall W.B., Kidd J.M., Campbell-Bright S., Miller M., Aris R.M. Clinical manifestations and impact of human metapneumovirus in healthy adults: A retrospective analysis of 28 patients over 2 years. Am. J. Respir. Crit. Care Med. 2011;183:4927.
    1. Li I.W., To K.K., Tang B.S., Chan K.H., Hui C.K., Cheng V.C., Yuen K.Y. Human metapneumovirus infection in an immunocompetent adult presenting as mononucleosis-like illness. J. Infect. 2008;56:389–392. doi: 10.1016/j.jinf.2008.03.005.
    1. Falsey A.R., Erdman D., Anderson L.J., Walsh E.E. Human metapneumovirus infections in young and elderly adults. J. Infect. Dis. 2003;187:785–790. doi: 10.1086/367901.
    1. Johnstone J., Majumdar S.R., Fox J.D., Marrie T.J. Human metapneumovirus pneumonia in adults: Results of a prospective study. Clin. Infect. Dis. 2008;46:571–574. doi: 10.1086/526776.
    1. van den Hoogen B.G. Respiratory tract infection due to human metapneumovirus among elderly patients. Clin. Infect. Dis. 2007;44:1159–1160. doi: 10.1086/513295.
    1. Tu C.C., Chen L.K., Lee Y.S., Ko C.F., Chen C.M., Yang H.H., Lee J.J. An outbreak of human metapneumovirus infection in hospitalized psychiatric adult patients in Taiwan. Scand. J. Infect. Dis. 2009;41:363–367. doi: 10.1080/00365540902849375.
    1. O'Gorman C., McHenry E., Coyle P.V. Human metapneumovirus in adults: A short case series. Euro. J. Clin. Micorbiol. Infect. Dis. 2006;25:190–192.
    1. Boivin G., De Serres G., Hamelin M.E., Cote S., Argouin M., Tremblay G., Maranda-Aubut R., Sauvageau C., Ouakki M., Boulianne N., et al. An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility. Clin. Infect. Dis. 2007;44:1152–1158.
    1. Pelletier G., Dery P., Abed Y., Boivin G. Respiratory tract reinfections by the new human metapneumovirus in an immunocompromised child. Emerg. Infect. Dis. 2002;8:976–978. doi: 10.3201/eid0809.020238.
    1. Syha R., Beck R., Hetzel J., Ketelsen D., Grosse U., Springer F., Horger M. Humane metapneumovirus (HMPV) associated pulmonary infections in immunocompromised adults-initial ct findings, disease course and comparison to respiratory-syncytial-virus (RSV) induced pulmonary infections. Eur. J. Radiol. 2012;81:4173–4178.
    1. Franquet T., Rodriguez S., Martino R., Salinas T., Gimenez A., Hidalgo A. Human metapneumovirus infection in hematopoietic stem cell transplant recipients: High-resolution computed tomography findings. J. Comput. Assist. Tomo. 2005;29:223–227. doi: 10.1097/01.rct.0000157087.14838.4c.
    1. Kamboj M., Gerbin M., Huang C.K., Brennan C., Stiles J., Balashov S., Park S., Kiehn T.E., Perlin D.S., Pamer E.G., et al. Clinical characterization of human metapneumovirus infection among patients with cancer. J. Infect. 2008;57:464–471. doi: 10.1016/j.jinf.2008.10.003.
    1. Hamelin M.E., Boivin G. Development and validation of an enzyme-linked immunosorbent assay for human metapneumovirus serology based on a recombinant viral protein. Clin. Diagn. Lab. Immunol. 2005;12:249–253.
    1. Cheng M.F., Chen B.C., Kao C.L., Kao C.H., Hsieh K.S., Liu Y.C. Human metapneumovirus as a causative agent of lower respiratory tract infection in four patients: The first report of human metapneumovirus infection confirmed by rna sequences in Taiwan. Scand. J. Infect. Dis. 2006;38:392–396. doi: 10.1080/00365540500388750.
    1. Chiu C.Y., Alizadeh A.A., Rouskin S., Merker J.D., Yeh E., Yagi S., Schnurr D., Patterson B.K., Ganem D., DeRisi J.L. Diagnosis of a critical respiratory illness caused by human metapneumovirus by use of a pan-virus microarray. J. Clin. Microbiol. 2007;45:2340–2343.
    1. Sookoian S., Castano G., Flichman D., Cello J. Effects of ribavirin on cytokine production of recall antigens and phytohemaglutinin-stimulated peripheral blood mononuclear cells. (Inhibitory effects of ribavirin on cytokine production) Ann. Hepatol. 2004;3:104–107.
    1. Graci J.D., Cameron C.E. Mechanisms of action of ribavirin against distinct viruses. Rev. Med. Virol. 2006;16:37–48. doi: 10.1002/rmv.483.
    1. Wyde P.R., Chetty S.N., Jewell A.M., Boivin G., Piedra P.A. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antivir. Res. 2003;60:51–59.
    1. Hamelin M.E., Prince G.A., Boivin G. Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection. Antimicrob. Agents Chemother. 2006;50:774–777. doi: 10.1128/AAC.50.2.774-777.2006.
    1. Shachor-Meyouhas Y., Ben-Barak A., Kassis I. Treatment with oral ribavirin and ivig of severe human metapneumovirus pneumonia (HMPV) in immune compromised child. Pediatr. Blood Canc. 2011;57:350–351. doi: 10.1002/pbc.23019.
    1. Egli A., Bucher C., Dumoulin A., Stern M., Buser A., Bubendorf L., Gregor M., Servida P., Sommer G., Bremerich J., et al. Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation. Infection. 2012;40:677–684. doi: 10.1007/s15010-012-0279-9.
    1. Kroll J.L., Weinberg A. Human metapneumovirus. Semin. Respir. Crit. Care Med. 2011;32:447–453. doi: 10.1055/s-0031-1283284.
    1. Shahda S., Carlos W.G., Kiel P.J., Khan B.A., Hage C.A. The human metapneumovirus: A case series and review of the literature. Transpl. Infect. Dis. 2011;13:324–328. doi: 10.1111/j.1399-3062.2010.00575.x.
    1. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics. 2003;112:1442–1446. doi: 10.1542/peds.112.6.1442.
    1. Ulbrandt N.D., Ji H., Patel N.K., Barnes A.S., Wilson S., Kiener P.A., Suzich J., McCarthy M.P. Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus. J. Gen. Virol. 2008;89:3113–3118. doi: 10.1099/vir.0.2008/005199-0.
    1. Feltes T.F., Cabalka A.K., Meissner H.C., Piazza F.M., Carlin D.A., Top F.H., Jr, Connor E.M., Sondheimer H.M. Cardiac Synagis Study Group. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J. Pediatr. 2003;143:532–540. doi: 10.1067/S0022-3476(03)00454-2.
    1. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102:531–537. doi: 10.1542/peds.102.3.531.
    1. Carbonell-Estrany X., Simoes E.A., Dagan R., Hall C.B., Harris B., Hultquist M., Connor E.M., Losonsky G.A. Motavizumab Study Group. Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: A noninferiority trial. Pediatrics. 2010;125:e35–e51. doi: 10.1542/peds.2008-1036.
    1. Ulbrandt N.D., Ji H., Patel N.K., Riggs J.M., Brewah Y.A., Ready S., Donacki N.E., Folliot K., Barnes A.S., Senthil K., et al. Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo. J. Virol. 2006;80:7799–7806. doi: 10.1128/JVI.00318-06.
    1. Hamelin M.E., Couture C., Sackett M., Kiener P., Suzich J., Ulbrandt N., Boivin G. The prophylactic administration of a monoclonal antibody against human metapneumovirus attenuates viral disease and airways hyperresponsiveness in mice. Antivir. Ther. 2008;13:39–46.
    1. Hamelin M.E., Gagnon C., Prince G.A., Kiener P., Suzich J., Ulbrandt N., Boivin G. Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model. Antivir. Res. 2010;88:31–37.
    1. Williams J.V., Chen Z., Cseke G., Wright D.W., Keefer C.J., Tollefson S.J., Hessell A., Podsiad A., Shepherd B.E., Sanna P.P., et al. A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo. J. Virol. 2007;81:8315–8324.
    1. Wyde P.R., Moylett E.H., Chetty S.N., Jewell A., Bowlin T.L., Piedra P.A. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by NMSO3 in tissue culture assays. Antivir. Res. 2004;63:51–59.
    1. Hamelin M.E., Prince G.A., Boivin G. Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection. Antimicrob. Agents Chemother. 2006;50:774–777. doi: 10.1128/AAC.50.2.774-777.2006.
    1. Kilham L., Ferm V.H. Congenital anomalies induced in hamster embryos with ribavirin. Science. 1977;195:413–414.
    1. Wyde P.R., Chetty S.N., Jewell A.M., Boivin G., Piedra P.A. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antivir. Res. 2003;60:51–59. doi: 10.1016/S0166-3542(03)00153-0.
    1. Deffrasnes C., Hamelin M.E., Prince G.A., Boivin G. Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus. Antimicrob. Agents Chemother. 2008;52:279–287. doi: 10.1128/AAC.00793-07.
    1. Miller S.A., Tollefson S., Crowe J.E., Jr, Williams J.V., Wright D.W. Examination of a fusogenic hexameric core from human metapneumovirus and identification of a potent synthetic peptide inhibitor from the heptad repeat 1 region. J. Virol. 2007;81:141–149. doi: 10.1128/JVI.01243-06.
    1. Sah D.W. Therapeutic potential of rna interference for neurological disorders. Life Sciences. 2006;79:1773–1780. doi: 10.1016/j.lfs.2006.06.011.
    1. Alvarez R., Elbashir S., Borland T., Toudjarska I., Hadwiger P., John M., Roehl I., Morskaya S.S., Martinello R., Kahn J., et al. RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy. Antimicrob. Agents Chemother. 2009;53:3952–3962. doi: 10.1128/AAC.00014-09.
    1. DeVincenzo J., Lambkin-Williams R., Wilkinson T., Cehelsky J., Nochur S., Walsh E., Meyers R., Gollob J., Vaishnaw A. A randomized, double-blind, placebo-controlled study of an rnai-based therapy directed against respiratory syncytial virus. Proc. Natl. Acad. Sci. U. S. A. 2010;107:8800–8805.
    1. Deffrasnes C., Cavanagh M.H., Goyette N., Cui K., Ge Q., Seth S., Templin M.V., Quay S.C., Johnson P.H., Boivin G. Inhibition of human metapneumovirus replication by small interfering RNA. Antivir. Ther. 2008;13:821–832.
    1. Preston F.M., Straub C.P., Ramirez R., Mahalingam S., Spann K.M. SiRNA against the g gene of human metapneumovirus. Virol. J. 2012;9:105-422X-9-105. doi: 10.1186/1743-422X-9-105.
    1. Wyde P.R., Moylett E.H., Chetty S.N., Jewell A., Bowlin T.L., Piedra P.A. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by NMSO3 in tissue culture assays. Antivir. Res. 2004;63:51–59.
    1. Herfst S., Fouchier R.A. Vaccination approaches to combat human metapneumovirus lower respiratory tract infections. J. Clin. Virol. 2008;41:49–52. doi: 10.1016/j.jcv.2007.10.022.
    1. Tang R.S., Mahmood K., Macphail M., Guzzetta J.M., Haller A.A., Liu H., Kaur J., Lawlor H.A., Stillman E.A., Schickli J.H., et al. A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in african green monkeys. Vaccine. 2005;23:1657–1667. doi: 10.1016/j.vaccine.2004.10.009.
    1. Skiadopoulos M.H., Biacchesi S., Buchholz U.J., Riggs J.M., Surman S.R., Amaro-Carambot E., McAuliffe J.M., Elkins W.R., St Claire M., Collins P.L., et al. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness. J. Virol. 2004;78:6927–6937.
    1. Herfst S., Fouchier R.A. Vaccination approaches to combat human metapneumovirus lower respiratory tract infections. J. Clin. Virol. 2008;41:49–52. doi: 10.1016/j.jcv.2007.10.022.
    1. Herfst S., de Graaf M., Schrauwen E.J., Ulbrandt N.D., Barnes A.S., Senthil K., Osterhaus A.D., Fouchier R.A., van den Hoogen B.G. Immunization of syrian golden hamsters with f subunit vaccine of human metapneumovirus induces protection against challenge with homologous or heterologous strains. J. Gen. Virol. 2007;88:2702–2709. doi: 10.1099/vir.0.83084-0.
    1. Cseke G., Wright D.W., Tollefson S.J., Johnson J.E., Crowe J.E., Jr, Williams J.V. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J. Virol. 2007;81:698–707.
    1. Mok H., Tollefson S.J., Podsiad A.B., Shepherd B.E., Polosukhin V.V., Johnston R.E., Williams J.V., Crowe J.E., Jr. An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats. J. Virol. 2008;82:11410–11418. doi: 10.1128/JVI.01688-08.
    1. Ryder A.B., Tollefson S.J., Podsiad A.B., Johnson J.E., Williams J.V. Soluble recombinant human metapneumovirus g protein is immunogenic but not protective. Vaccine. 2010;28:4145–4152. doi: 10.1016/j.vaccine.2010.04.007.
    1. Yim K.C., Cragin R.P., Boukhvalova M.S., Blanco J.C., Hamlin M.E., Boivin G., Porter D.D., Prince G.A. Human metapneumovirus: Enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged. Vaccine. 2007;25:5034–5040. doi: 10.1016/j.vaccine.2007.04.075.
    1. Hamelin M.E., Couture C., Sackett M.K., Boivin G. Enhanced lung disease and th2 response following human metapneumovirus infection in mice immunized with the inactivated virus. J. Gen. Virol. 2007;88:3391–3400. doi: 10.1099/vir.0.83250-0.
    1. de Swart R.L., van den Hoogen B.G., Kuiken T., Herfst S., van Amerongen G., Yuksel S., Sprong L., Osterhaus A.D. Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection. Vaccine. 2007;25:8518–8528.
    1. Buchholz U.J., Nagashima K., Murphy B.R., Collins P.L. Live vaccines for human metapneumovirus designed by reverse genetics. Expet. Rev. Vaccine. 2006;5:695–706. doi: 10.1586/14760584.5.5.695.
    1. Boivin G., De Serres G., Hamelin M.E., Cote S., Argouin M., Tremblay G., Maranda-Aubut R., Sauvageau C., Ouakki M., Boulianne N., et al. An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility. Clin. Infect. Dis. 2007;44:1152–1158. doi: 10.1086/513204.
    1. Osbourn M., McPhie K.A., Ratnamohan V.M., Dwyer D.E., Durrheim D.N. Outbreak of human metapneumovirus infection in a residential aged care facility. Comm. Dis. Intell. 2009;33:38–40.
    1. Louie J.K., Schnurr D.P., Pan C.Y., Kiang D., Carter C., Tougaw S., Ventura J., Norman A., Belmusto V., Rosenberg J., et al. A summer outbreak of human metapneumovirus infection in a long-term-care facility. J. Infect. Dis. 2007;196:705–708.

    1. http://www.wip.nl.

    1. Siegel J.D., Rhinehart E., Jackson M., Chiarello L. Health Care Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: Preventing transmission of infectious agents in health care settings. Am. J. Infect. Contr. 2007;35:S65–S164. doi: 10.1016/j.ajic.2007.10.007.
    1. Duncan C.B., Walsh E.E., Peterson D.R., Lee F.E., Falsey A.R. Risk factors for respiratory failure associated with respiratory syncytial virus infection in adults. J. Infect. Dis. 2009;200:1242–1246. doi: 10.1086/605948.
    1. Beckham J.D., Cadena A., Lin J., Piedra P.A., Glezen W.P., Greenberg S.B., Atmar R.L. Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J. Infect. 2005;50:322–330. doi: 10.1016/j.jinf.2004.07.011.
    1. Walsh E.E., Falsey A.R., Hennessey P.A. Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am. J. Respir. Crit. Care Med. 1999;160:791–795.
    1. Johnstone J., Majumdar S.R., Fox J.D., Marrie T.J. Viral Infection in Adults Hospitalized with Community-Acquired Pneumonia: Prevalence, Pathogens, and Presentation. Chest. 2008;134:1141–1148. doi: 10.1378/chest.08-0888.
    1. Hamelin M.E., Boivin G. Human metapneumovirus: A ubiquitous and long-standing respiratory pathogen. J. Pediatr. Infect. Dis. 2005;24:S203–S207. doi: 10.1097/01.inf.0000188158.27840.7c.
    1. Martinello R.A., Esper F., Weibel C., Ferguson D., Landry M.L., Kahn J.S. Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease. J. Infect. 2006;53:248–254. doi: 10.1016/j.jinf.2005.11.010.
    1. Williams J.V., Crowe J.E., Jr, Enriquez R., Minton P., Peebles R.S., Jr, Hamilton R.G., Higgins S., Griffin M., Hartert T.V. Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J. Infect. Dis. 2005;192:1149–1153. doi: 10.1086/444392.
    1. Williams J.V., Crowe J.E., Jr, Enriquez R., Minton P., Peebles R.S., Jr, Hamilton R.G., Higgins S., Griffin M., Hartert T.V. Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J. Infect. Dis. 2005;192:1149–1153. doi: 10.1086/444392.
    1. Haas L.E., de Rijk N.X., Thijsen S.F. Human metapneumovirus infections on the ICU: A report of three cases. Ann. Intensive Care. 2012;2:30. doi: 10.1186/2110-5820-2-30.
    1. Miller R.A. The aging immune system: Primer and prospectus. Science. 1996;273:70–74.
    1. Honda H., Iwahashi J., Kashiwagi T., Imamura Y., Hamada N., Anraku T., Ueda S., Kanda T., Takahashi T., Morimoto S. Outbreak of human metapneumovirus infection in elderly inpatients in Japan. J. Am. Geriatr. Soc. 2006;54:177–180. doi: 10.1111/j.1532-5415.2005.00575_10.x.
    1. Liao R.S., Appelgate D.M., Pelz R.K. An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility for the elderly in Oregon. J. Clin. Virol. 2012;53:171–173. doi: 10.1016/j.jcv.2011.10.010.
    1. Raza K., Ismailjee S.B., Crespo M., Studer S.M., Sanghavi S., Paterson D.L., Kwak E.J., Rinaldo C.R., Jr, Pilewski J.M., McCurry K.R., et al. Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin. J. Heart Lung Transplant. 2007;26:862–864.
    1. Huck B., Egger M., Bertz H., Peyerl-Hoffman G., Kern W.V., Neumann-Haefelin D., Falcone V. Human metapneumovirus infection in a hematopoietic stem cell transplant recipient with relapsed multiple myeloma and rapidly progressing lung cancer. J. Clin. Microbiol. 2006;44:2300–2303.
    1. Kamble R.T., Bollard C., Demmler G., LaSala P.R., Carrum G. Human metapneumovirus infection in a hematopoietic transplant recipient. Bone Marrow Transplant. 2007;40:699–700. doi: 10.1038/sj.bmt.1705781.
    1. Muller A., Kupfer B., Vehreschild J., Cornely O., Kaiser R., Seifert H., Viazov S., Tillmann R.L., Franzen C., Simon A., et al. Fatal pneumonia associated with human metapneumovirus (HMPV) in a patient with myeloid leukemia and adenocarcinoma in the lung. Eur. J. Med. Res. 2007;12:183–184.
    1. Kamboj M., Gerbin M., Huang C.K., Brennan C., Stiles J., Balashov S., Park S., Kiehn T.E., Perlin D.S., Pamer E.G., et al. Clinical Characterization of Human Metapneumovirus Infection among Patients with Cancer. J. Infect. 2008;57:464–471. doi: 10.1016/j.jinf.2008.10.003.
    1. Williams J.V., Martino R., Rabella N., Otegui M., Parody R., Heck J.M., Crowe J.E., Jr. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J. Infect. Dis. 2005;192:1061–1065. doi: 10.1086/432732.
    1. Martino R., Porras R.P., Rabella N., Williams J.V., Ramila E., Margall N., Labeaga R., Crowe J.E., Jr, Coll P., Sierra J. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol. Blood Marrow Transplant. 2005;11:781–796.
    1. Peck A.J., Englund J.A., Kuypers J., Guthrie K.A., Corey L., Morrow R., Hackman R.C., Cent A., Boeckh M. Respiratory virus infection among hematopoietic cell transplant recipients: Evidence for asymptomatic parainfluenza virus infection. Blood. 2007;110:1681–1688.
    1. Debiaggi M., Canducci F., Sampaolo M., Marinozzi M.C., Parea M., Terulla C., Colombo A.A., Alessandrino E.P., Bragotti L.Z., Arghittu M., et al. Persistent symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients. J. Infect. Dis. 2006;194:474–478. doi: 10.1086/505881.
    1. Sumino K.C., Agapov E., Pierce R.A., Trulock E.P., Pfeifer J.D., Ritter J.H., Gaudreault-Keener M., Storch G.A., Holtzman M.J. Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment. J. Infect. Dis. 2005;192:1052–1060. doi: 10.1086/432728.
    1. Debur M.C., Vidal L.R., Stroparo E., Nogueira M.B., Almeida S.M., Takahashi G.A., Rotta I., Pereira L.A., Silveira C.S., Delfraro A., et al. Impact of human metapneumovirus infection on in and outpatients for the years 2006-2008 in Southern Brazil. Memorias do Instituto Oswaldo Cruz. 2010;105:1010–1018. doi: 10.1590/S0074-02762010000800010.
    1. Englund J.A., Boeckh M., Kuypers J., Nichols W.G., Hackman R.C., Morrow R.A., Fredricks D.N., Corey L. Brief communication: Fatal human metapneumovirus infection in stem-cell transplant recipients. Ann. Intern. Med. 2006;144:344–349.
    1. Cane P.A., van den Hoogen B.G., Chakrabarti S., Fegan C.D., Osterhaus A.D. Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease. Bone Marrow Transplant. 2003;31:309–310. doi: 10.1038/sj.bmt.1703849.
    1. Weinberg A., Lyu D.M., Li S., Marquesen J., Zamora M.R. Incidence and morbidity of human metapneumovirus and other community-acquired respiratory viruses in lung transplant recipients. Transpl. Infect. Dis. 2010;12:330–335. doi: 10.1111/j.1399-3062.2010.00509.x.
    1. Larcher C., Geltner C., Fischer H., Nachbaur D., Muller L.C., Huemer H.P. Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology. J. Heart Lung Transplant. 2005;24:1891–1901. doi: 10.1016/j.healun.2005.02.014.
    1. Kumar D., Erdman D., Keshavjee S., Peret T., Tellier R., Hadjiliadis D., Johnson G., Ayers M., Siegal D., Humar A. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am. J. Transplant. 2005;5:2031–2036. doi: 10.1111/j.1600-6143.2005.00971.x.
    1. Sharples L.D., McNeil K., Stewart S., Wallwork J. Risk factors for bronchiolitis obliterans: A systematic review of recent publications. J. Heart Lung Transplant. 2002;21:271–281. doi: 10.1016/S1053-2498(01)00360-6.
    1. Kukavica-Ibrulj I., Hamelin M.E., Prince G.A., Gagnon C., Bergeron Y., Bergeron M.G., Boivin G. Infection with human metapneumovirus predisposes mice to severe pneumococcal pneumonia. J. Virol. 2009;83:1341–1349.
    1. Ludewick H.P., Aerts L., Hamelin M.E., Boivin G. Long-term impairment of streptococcus pneumoniae lung clearance is observed after initial infection with influenza a virus but not human metapneumovirus in mice. J. Gen. Virol. 2011;92:1662–1665. doi: 10.1099/vir.0.030825-0.
    1. Louie J.K., Schnurr D.P., Pan C.Y., Kiang D., Carter C., Tougaw S., Ventura J., Norman A., Belmusto V., Rosenberg J., et al. A summer outbreak of human metapneumovirus infection in a long-term-care facility. J. Infect. Dis. 2007;196:705–708. doi: 10.1086/519846.
    1. Bonney D., Razali H., Turner A., Will A. Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin. Br. J. Haematol. 2009;145:667–669. doi: 10.1111/j.1365-2141.2009.07654.x.
    1. Safdar A. Immune modulatory activity of ribavirin for serious human metapneumovirus disease: Early i.v. therapy may improve outcomes in immunosuppressed SCT recipients. Bone Marrow Transplant. 2008;41:707–708. doi: 10.1038/bmt.2008.80.
    1. Shachor-Meyouhas Y., Ben-Barak A., Kassis I. Treatment with oral ribavirin and IVIG of severe human metapneumovirus pneumonia (HMPV) in immune compromised child. Pediatr. Blood Canc. 2011;57:350–351. doi: 10.1002/pbc.23019.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner